FEBRUARY 26-28, 2018
SAN FRANCISCO, CA
Data2Discovery presents a unique session at the event titled Reinventing Drug Discovery with AI, led by Data2Discovery's Robin McEntire and Dr. David Wild. Synopsis: Drug discovery is at a critical turning point. Traditional paradigms have mostly failed to bring successful new treatments out of clinical trials, and preclinical drug discovery is ripe for disruptive innovation. In this session, we demonstrate how AI, Machine Learning, Graph Analytic technologies, and linked data will break down historical silos and paradigms, providing promising new transformative opportunities for successful drug discovery.